0 152

Cited 0 times in

PS2-3 Neoadjuvant pembrolizumab/placebo + chemo, followed by adjuvant pembrolizumab/placebo in early TNBC: Asian subgroup

Authors
 Masato Takahashi  ;  Javier Cortés  ;  Rebecca Dent  ;  Lajos Pusztai  ;  Heather Mcarthur  ;  Sherko Kümmel  ;  Carsten Denkert  ;  Yeon Hee Park  ;  Seock-Ah Im  ;  Jin-Hee Ahn  ;  Hirofumi Mukai  ;  Chiun-Sheng Huang  ;  Shin-Cheh Chen  ;   Min Hwan Kim  ;  Liyi Jia  ;  Xin Tong Li  ;  Konstantinos Tryfonidis  ;  Vassiliki Karantza  ;  Hiroji Iwata  ;  Peter Schmid 
Citation
 ANNALS OF ONCOLOGY, Vol.33(suppl 6) : S465-S465, 2022-07 
Journal Title
ANNALS OF ONCOLOGY
ISSN
 0923-7534 
Issue Date
2022-07
Full Text
https://www.sciencedirect.com/science/article/pii/S0923753422012649
DOI
10.1016/j.annonc.2022.05.066
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Min Hwan(김민환) ORCID logo https://orcid.org/0000-0002-1595-6342
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194685
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links